ESC Professional Premium Access

Basic and Translational Late-Breaking Science 1

Event: ESC Congress 2022
Topic: Basic Science
Session type: Basic and Translational Late-Breaking Science
Date: 28 August 2022
Time: 08:30 - 09:30

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

Intravascular administration of soluble Sars-CoV-2 Spike protein triggers non-infective heart and lung inflammation and vascular pericytes rarefaction in healthy mice.

Speaker: Doctor E. Avolio (Bristol, GB)

CRISPR/Cas9 editing of CaMKII as a strategy for cardioprotection against ischemia/reperfusion injury.

Speaker: Doctor S. Lebek (Dallas, US)

Is empagliflozin still cardioprotective in SGLT2 KO mice?

Speaker: Miss S. Chen (Amsterdam, NL)

Plasma of COVID-19 positive patients promote oxidative stress and proinflammatory responses in endothelial cells: Potential role of the pro-inflammatory cytokines/SGLT2 pathway.

Speaker: Mr A. Mroueh (Strasbourg, FR)

4 speakers from this session

Doctor Elisa Avolio

University of Bristol, Bristol (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Doctor Simon Lebek

University of Texas Southwestern Medical Center, Dallas (United States of America)
1 presentation
0 follower

Miss Sha Chen

AMC Medical Research BV, Amsterdam (Netherlands (The))
1 presentation
0 follower

Mr Ali Mroueh

University of Strasbourg, Strasbourg (France)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk